Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization (NCT04825314) | Clinical Trial Compass
UnknownNot Applicable
Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization
Egypt100 participantsStarted 2020-05-21
Plain-language summary
Eighty percent of nosocomial UTI caused by indwelling urinary catheters and so known-as catheter-associated UTI. CAUTI leads to multiple local and systemic derangements such as suprapubic pain, dysuria, cystitis, pyelonephritis, septicemia, and even septic shock.
This study will be conducted up on 100 patients (50 per each group) with long term catheterization to assess efficacy of noble metal alloy coated catheter in reducing CAUTI.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- Patient under age of 80 years old who need prolonged urethral catheterization (more than 2 weeks) as a method of bladder drainage.
Exclusion Criteria:
* Patients with current or recent symptomatic urinary tract infection.
* Antibiotic use currently or within 7 days prior to inclusion.
* Known hypersensitivity to latex, silver salts or hydrogel.
* Patients with recent surgical intervention in the urinary tract.
* Patients with anatomic or functional upper urinary tract issues (e.g reflux, stones, etc.)
* Uncontrolled DM. Patients on corticosteroid treatment. Immunosuppressed patients. Patients received pelvic irradiation.